NCT04739670 2024-03-01
BELLA
Peter MacCallum Cancer Centre, Australia
Phase 2 Unknown
Clinical Trials
36 trialsNCT03567720 2023-06-01
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
Phase 2 Unknown
NCT05872412 2023-05-25
Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Unknown
NCT00431704 2023-03-24
VinCaT
National Cancer Institute, Naples
Phase 2 Unknown
NCT05749016 2023-03-01
Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT03907800 2022-10-27
NeoPATH
Ruijin Hospital
Phase 2 Unknown
NCT05580887 2022-10-14
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center
Unknown
NCT05491694 2022-08-08
HIFU
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05483439 2022-08-05
A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer
Shengjing Hospital
Phase 2 Unknown
NCT05438706 2022-06-30
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT02341911 2022-04-20
TNBC
Fudan University
Phase 2 Unknown
NCT03238495 2021-12-07
HERMET
University of Kansas Medical Center
Phase 2 Unknown
NCT04681911 2020-12-23
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT04143906 2019-10-30
Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT03756064 2019-08-13
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01372579 2019-06-07
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
Northwestern University
Phase 2 Unknown
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT03876886 2019-03-21
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
ChineseAMS
Phase 3 Unknown
NCT00532727 2019-02-20
TNT
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT03735082 2018-11-08
Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03650738 2018-08-29
This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT02396108 2017-02-03
Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer
National University Hospital, Singapore
Phase 1/2 Unknown
NCT02207335 2015-12-22
Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT02510781 2015-07-29
A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs
Hospital Affiliated to Military Medical Science, Beijing
Phase 2 Unknown
NCT02041338 2014-11-25
Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02059876 2014-02-12
Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer
Guangdong Provincial People's Hospital
Phase 2 Unknown
NCT00002627 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00002628 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00012311 2014-01-06
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002780 2013-12-19
Biological Therapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00002616 2013-09-20
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01428414 2012-08-23
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
Fudan University
Phase 2 Unknown
NCT01378533 2011-12-28
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
ChineseAMS
Phase 3 Unknown
NCT01276769 2011-11-16
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT00930475 2011-01-26
Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer
Charite University, Berlin, Germany
Phase 1/2 Unknown
NCT00669747 2008-10-02
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Windy Hill Medical, Inc.
Phase 2 Unknown